<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1097/TP.0000000000000050</dc:identifier><dc:language>eng</dc:language><dc:creator>García-Gil, Francisco A</dc:creator><dc:creator>Fuentes-Broto, Lorena</dc:creator><dc:creator>Albendea, Carlos D.</dc:creator><dc:creator>Serrano, María Trinidad</dc:creator><dc:creator>Roselló-Catafau, Joan</dc:creator><dc:creator>Lampreave, Fermín</dc:creator><dc:creator>López-Pingarrón, Laura</dc:creator><dc:creator>Escartín, Jorge</dc:creator><dc:creator>Soria, Joaquín</dc:creator><dc:creator>Garcia, ,Joaquín J</dc:creator><dc:creator>Fernández-Cruz, Laureano</dc:creator><dc:title>Evaluation of Institut Georges Lopez-1 preservation solution in pig pancreas transplantation: a pilot study</dc:title><dc:identifier>ART-2014-85812</dc:identifier><dc:description>Background. Institut Georges Lopez-1 preservation solution (IGL-1) is an emerging extracellular-type electrolyte solution, low in viscosity, containing polyethylene glycol 35 as a colloid. Although IGL-1 has shown beneficial outcomes in kidney and liver preservation, this pilot study is the first to evaluate the efficacy of IGL-1 in pancreas transplantation (PT) compared with the University of Wisconsin solution (UW)
Methods. Sixteen Landrace pigs underwent allogeneic PT with 16 hr of cold ischemia. Grafts were preserved with IGL-1 (n=8) or UW (n=8). No immunosuppression was administered. We analyzed graft function, the acute-phase response, and oxidative stress in the pancreatic graft monitoring membrane fluidity and lipid peroxidation@@@Results. All eight grafts with IGL-1, but only six with UW, were functioning. Graft failures with UW resulted from graft thrombosis. There were no differences between the two solutions in the number of normoglycemic days (IGL-1: 11.5T6.2 versus UW: 8.5T4.4 days, P=0.1357), nor in lipid peroxidation during 16-hr cold ischemia (P=0.672), or reperfusion (P=0.185), but IGL-1 prevented changes in membrane fluidity after reperfusion when compared with UW (P=0.026)
Conclusion. IGL-1 offered the same degree of safety and effectiveness as UW in our model of pig PT with 16 hr of cold ischemia.</dc:description><dc:date>2014</dc:date><dc:source>http://zaguan.unizar.es/record/130264</dc:source><dc:doi>10.1097/TP.0000000000000050</dc:doi><dc:identifier>http://zaguan.unizar.es/record/130264</dc:identifier><dc:identifier>oai:zaguan.unizar.es:130264</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/ISCIII-PI10-2877</dc:relation><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/ISCIII-RD06-0013-1017</dc:relation><dc:identifier.citation>Transplantation 97, 9 (2014), 901-907</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/closedAccess</dc:rights></dc:dc>

</collection>